Peptides Without Needles: What Oral, Nasal and Topical Forms Deliver

A few peptides work without a needle, and they are FDA-approved drugs engineered for the route. Semaglutide tablets, oral octreotide, desmopressin tablets and nasal spray, and calcitonin nasal spray all reach the blood, but their labels show how little gets through: about 1% to 2% of a Wegovy tablet dose, and 3% to 5% of a calcitonin spray compared with an injection.^[1][7] For the research peptides sold as capsules, nasal sprays, creams or drops, no one has published a human study showing how much reaches the blood. FDA found no such data for BPC-157 by mouth, nose or skin.^[11]

Why peptides are usually injected

Peptides are chains of amino acids, and the gut treats them like food. Swallowed peptides meet digestive enzymes that cut them apart, and what survives crosses the gut wall poorly. Researchers at Novo Nordisk summed up the problem as poor absorption across the gut barrier plus extensive breakdown by enzymes.^[3] HHS put it more bluntly in its 2026 compounding policy: adequate oral absorption of peptides is “inherently difficult and complex.”^[10] An injection under the skin avoids both problems. Wegovy’s label puts the absorption of injected semaglutide at 89%, against 1% to 2% for its tablet.^[1]

Needle-free peptides that are FDA-approved

Three patterns stand out. First, the oral successes needed a purpose-built formulation. Semaglutide tablets contain SNAC, which protects the peptide from enzymes in a small zone around the dissolving tablet and helps it cross the stomach lining; the absorption depends on the specific compound and needs SNAC to happen at all.^[3] The tablets come with strict rules, including a half-hour gap after each dose before any food, drink or other medicine.^[2] Mycapssa is an enteric-coated capsule with its own absorption-enhancing ingredients, taken on an empty stomach.^[4]

Second, the oral dose has to be far larger. The Wegovy tablet maintenance dose is 25 mg every day, while the injection is 2.4 mg once a week.^[1] For octreotide, 20 mg by mouth matched the exposure of 0.1 mg injected, a 200-fold difference.^[4] Third, some oral peptides are not meant to be absorbed. Linaclotide, a 14-amino-acid peptide, acts on the gut lining and leaves almost no trace in the blood.^[8] A peptide that works in the gut tells you nothing about whether a different peptide taken by mouth will reach a tendon or a muscle.

For desmopressin, the nose beats the gut: the tablet delivers about 5% of what the nasal form does.^[5] By injection standards the nose is still a poor route. Calcitonin spray delivers 3% to 5% of what an intramuscular injection does.^[7] The GLP-1 drugs that are available as pills are listed in FDA-approved peptides.

Oral research peptides: capsules and tablets

BPC-157 is the research peptide most often sold as a capsule. FDA’s 2026 review found no human pharmacokinetic data for BPC-157 taken by mouth. A phase 1 trial of an oral BPC-157 tablet was registered, but no results were posted and FDA could not find a published study.^[11] In the two human studies that gave BPC-157 as an enema and measured blood levels, BPC-157 was not detected in plasma.^[11]

Since October 28, 2026, HHS has said it does not intend to take enforcement action against 503A pharmacies that compound BPC-157 acetate as an oral product, among other routes, under strict conditions. One condition applies only to oral forms: the pharmacy is expected to keep documentation that the specific formulation it dispenses achieves adequate oral absorption in humans.^[10] No such human data has been published. A supplement-store capsule falls outside the policy entirely. The details, including the rat data behind the oral claims, are in oral BPC-157 capsules. KPV is the other policy peptide covered by mouth, and its record is in KPV by mouth and on the skin.

Nasal sprays

Nasal sprays of BPC-157 and TB-500 are sold online. FDA cited one seller for offering both as injections and as nasal sprays under a “research purpose only” label, and warned that nasal products can be absorbed quickly through the blood-rich lining of the nose, with possible effects on heart rate and blood pressure. If the product contains toxic substances, it can cause bleeding, ulcers or a hole in the nasal septum.^[12] FDA found no human absorption data for nasal BPC-157 and flagged the nasal route, like injection, as one where it may provoke an immune reaction.^[11]

The HHS policy covers only one peptide as a nasal product: Semax, by the intranasal route. It does not cover BPC-157, TB-500, KPV, MOTS-c or Epitalon as nasal sprays.^[10]

Creams, patches and serums

Skin keeps out large molecules. A dermatology review set out the “500 dalton rule”: a compound must weigh under 500 daltons to pass the skin’s outer layer.^[9] BPC-157 weighs about 1,420 daltons, nearly three times that limit.^[10] FDA found no human absorption data for BPC-157 applied to the skin.^[11] The HHS policy covers topical BPC-157 and topical KPV from a 503A pharmacy.^[10] That makes a topical product lawful to compound under the policy’s conditions. It does not show that the peptide gets past the skin, or that it does anything once it does.

Sublingual drops and lozenges

Under-the-tongue semaglutide drops are sold online. None is FDA-approved, and nobody has published a human measurement of the semaglutide that drops deliver to the bloodstream. The approved tablet, with its absorption enhancer and dosing rules, absorbs about 1% to 2%.^[1] The evidence is reviewed in sublingual semaglutide drops.

What to ask about any needle-free peptide

• Is this exact product FDA-approved for this route? If so, its label states how much is absorbed. If not, nobody has had to show that it is absorbed at all.
• Is there a human absorption study? For oral, nasal, topical and sublingual BPC-157, FDA found none.^[11]
• Does the route match the policy? Under the HHS policy, BPC-157 may be compounded as an oral or topical product, KPV as oral or topical, Semax as a nasal spray, and TB-500, MOTS-c and Epitalon only as injections.^[10]
• Who made it? A research-use-only spray or capsule has no prescription, no pharmacy and no batch testing behind it. The safety record across product types is in are peptides safe.